S&P 500   4,289.42 (+0.36%)
DOW   34,016.03 (+0.11%)
QQQ   329.83 (+0.41%)
AAPL   174.52 (-0.02%)
MSFT   291.38 (+0.02%)
META   175.24 (+0.22%)
GOOGL   120.54 (+0.83%)
AMZN   142.21 (+0.08%)
TSLA   910.25 (-0.19%)
NVDA   187.51 (+2.27%)
NIO   19.92 (-0.80%)
BABA   90.64 (+0.97%)
AMD   100.76 (+2.53%)
MU   63.09 (+2.39%)
T   18.51 (+0.49%)
CGC   3.76 (-7.39%)
F   16.17 (+0.87%)
GE   79.40 (-0.65%)
DIS   122.84 (+0.02%)
AMC   19.65 (-8.01%)
PYPL   100.31 (+0.90%)
PFE   48.59 (-1.38%)
NFLX   245.17 (+1.67%)
S&P 500   4,289.42 (+0.36%)
DOW   34,016.03 (+0.11%)
QQQ   329.83 (+0.41%)
AAPL   174.52 (-0.02%)
MSFT   291.38 (+0.02%)
META   175.24 (+0.22%)
GOOGL   120.54 (+0.83%)
AMZN   142.21 (+0.08%)
TSLA   910.25 (-0.19%)
NVDA   187.51 (+2.27%)
NIO   19.92 (-0.80%)
BABA   90.64 (+0.97%)
AMD   100.76 (+2.53%)
MU   63.09 (+2.39%)
T   18.51 (+0.49%)
CGC   3.76 (-7.39%)
F   16.17 (+0.87%)
GE   79.40 (-0.65%)
DIS   122.84 (+0.02%)
AMC   19.65 (-8.01%)
PYPL   100.31 (+0.90%)
PFE   48.59 (-1.38%)
NFLX   245.17 (+1.67%)
S&P 500   4,289.42 (+0.36%)
DOW   34,016.03 (+0.11%)
QQQ   329.83 (+0.41%)
AAPL   174.52 (-0.02%)
MSFT   291.38 (+0.02%)
META   175.24 (+0.22%)
GOOGL   120.54 (+0.83%)
AMZN   142.21 (+0.08%)
TSLA   910.25 (-0.19%)
NVDA   187.51 (+2.27%)
NIO   19.92 (-0.80%)
BABA   90.64 (+0.97%)
AMD   100.76 (+2.53%)
MU   63.09 (+2.39%)
T   18.51 (+0.49%)
CGC   3.76 (-7.39%)
F   16.17 (+0.87%)
GE   79.40 (-0.65%)
DIS   122.84 (+0.02%)
AMC   19.65 (-8.01%)
PYPL   100.31 (+0.90%)
PFE   48.59 (-1.38%)
NFLX   245.17 (+1.67%)
S&P 500   4,289.42 (+0.36%)
DOW   34,016.03 (+0.11%)
QQQ   329.83 (+0.41%)
AAPL   174.52 (-0.02%)
MSFT   291.38 (+0.02%)
META   175.24 (+0.22%)
GOOGL   120.54 (+0.83%)
AMZN   142.21 (+0.08%)
TSLA   910.25 (-0.19%)
NVDA   187.51 (+2.27%)
NIO   19.92 (-0.80%)
BABA   90.64 (+0.97%)
AMD   100.76 (+2.53%)
MU   63.09 (+2.39%)
T   18.51 (+0.49%)
CGC   3.76 (-7.39%)
F   16.17 (+0.87%)
GE   79.40 (-0.65%)
DIS   122.84 (+0.02%)
AMC   19.65 (-8.01%)
PYPL   100.31 (+0.90%)
PFE   48.59 (-1.38%)
NFLX   245.17 (+1.67%)
NYSE:NTR

Nutrien - NTR Stock Forecast, Price & News

$92.52
+0.88 (+0.96%)
(As of 08/18/2022 03:11 PM ET)
Add
Compare
Today's Range
$92.21
$93.49
50-Day Range
$71.90
$92.38
52-Week Range
$57.45
$117.25
Volume
121,129 shs
Average Volume
2.41 million shs
Market Capitalization
$50.18 billion
P/E Ratio
7.49
Dividend Yield
2.10%
Price Target
$105.33

Nutrien MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.72 Rating Score
Upside/​Downside
14.0% Upside
$105.33 Price Target
Short Interest
Healthy
1.19% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-6.86
Upright™ Environmental Score
News Sentiment
-0.11mentions of Nutrien in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-7.03%
From $16.35 to $15.20 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.61 out of 5 stars

Basic Materials Sector

38th out of 171 stocks

Agricultural Chemicals Industry

3rd out of 9 stocks

NTR stock logo

About Nutrien (NYSE:NTR) Stock

Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on NTR. Barclays lowered their target price on Nutrien from $126.00 to $105.00 and set an "overweight" rating for the company in a report on Wednesday, August 10th. Piper Sandler boosted their target price on Nutrien from $112.00 to $125.00 and gave the company an "overweight" rating in a research note on Tuesday, May 31st. JPMorgan Chase & Co. set a $120.00 price target on shares of Nutrien in a research note on Wednesday, May 4th. Mizuho boosted their price objective on shares of Nutrien from $94.00 to $124.00 in a research report on Friday, April 29th. Finally, TD Securities decreased their target price on shares of Nutrien from $130.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, July 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Nutrien has a consensus rating of "Moderate Buy" and a consensus price target of $105.33.

Nutrien Price Performance

Shares of NTR opened at $91.64 on Thursday. The company's 50-day moving average is $82.43 and its 200-day moving average is $90.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.21 and a quick ratio of 0.75. The firm has a market capitalization of $49.70 billion, a PE ratio of 7.41, a PEG ratio of 0.68 and a beta of 0.93. Nutrien has a fifty-two week low of $57.45 and a fifty-two week high of $117.25.

Nutrien Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a $0.48 dividend. The ex-dividend date is Thursday, September 29th. This represents a $1.92 annualized dividend and a yield of 2.10%. Nutrien's dividend payout ratio is currently 15.53%.

Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

NTR Stock News Headlines

Citigroup Increases Nutrien (NYSE:NTR) Price Target to $102.00
Why Nutrien's Strong Results Missed Analyst Estimates
Barclays Lowers Nutrien (NYSE:NTR) Price Target to $105.00
Nutrien (NYSE:NTR) Upgraded by Scotiabank to "Sector Outperform"
Nutrien (NYSE:NTR) Price Target Raised to $102.00 at Citigroup
Nutrien (NTR) Misses Q2 Earnings and Revenue Estimates
Nutrien's Earnings Outlook
Earnings Outlook For Nutrien
See More Headlines
Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

NTR Company Calendar

Last Earnings
11/01/2021
Ex-Dividend for 7/15 Dividend
6/29/2022
Dividend Payable
7/15/2022
Today
8/18/2022
Ex-Dividend for 10/14 Dividend
9/29/2022
Dividend Payable
10/14/2022
Next Earnings (Estimated)
11/07/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Employees
23,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$105.33
High Stock Price Forecast
$135.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+13.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.72
Research Coverage
18 Analysts

Profitability

Net Income
$3.15 billion
Pretax Margin
26.01%

Debt

Sales & Book Value

Annual Sales
$27.71 billion
Cash Flow
$9.98 per share
Book Value
$49.07 per share

Miscellaneous

Free Float
525,589,000
Market Cap
$50.18 billion
Optionable
Optionable
Beta
0.93

Social Links


Key Executives

  • Mr. Kenneth A. Seitz (Age 52)
    Interim Pres & CEO
    Comp: $1.71M
  • Mr. Pedro Farah
    Exec. VP & CFO
  • Ms. Noralee M. Bradley
    Exec. VP & Chief Legal Officer
  • Mr. Raef M. Sully (Age 55)
    Exec. VP and CEO of Phosphate & Nitrogen
    Comp: $1.51M
  • Mr. Brent D. Poohkay (Age 52)
    Exec. VP & Chief Information Officer
  • Jeff Holzman
    VP of Investor Relations
  • Megan Fielding
    VP of Brand & Culture Communications
  • Ms. Candace Laing
    Sr. VP & Chief HR Officer
  • Dr. Stephen Francis Dowdle Ph.D. (Age 71)
    Pres of PCS Sales
  • Jason Newton
    Head Economist













NTR Stock - Frequently Asked Questions

Should I buy or sell Nutrien stock right now?

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NTR shares.
View NTR analyst ratings
or view top-rated stocks.

What is Nutrien's stock price forecast for 2022?

18 brokers have issued 12 month price targets for Nutrien's stock. Their NTR share price forecasts range from $70.00 to $135.00. On average, they anticipate the company's share price to reach $105.33 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts price targets for NTR
or view top-rated stocks among Wall Street analysts.

How have NTR shares performed in 2022?

Nutrien's stock was trading at $75.20 on January 1st, 2022. Since then, NTR stock has increased by 21.9% and is now trading at $91.64.
View the best growth stocks for 2022 here
.

When is Nutrien's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our NTR earnings forecast
.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) issued its quarterly earnings results on Monday, November, 1st. The company reported $1.38 EPS for the quarter, topping analysts' consensus estimates of $1.23 by $0.15. The business earned $6.02 billion during the quarter, compared to the consensus estimate of $5.59 billion. Nutrien had a net margin of 19.43% and a trailing twelve-month return on equity of 28.14%. Nutrien's revenue was up 42.5% on a year-over-year basis. During the same quarter last year, the business earned $0.23 EPS.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Friday, August 5th. Investors of record on Friday, September 30th will be paid a dividend of $0.48 per share on Friday, October 14th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for NTR
.

Is Nutrien a good dividend stock?

Nutrien (NYSE:NTR) pays an annual dividend of $1.92 per share and currently has a dividend yield of 2.10%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 15.53%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NTR will have a dividend payout ratio of 12.63% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of $15.80-$17.80 for the period, compared to the consensus estimate of $17.04. The company issued revenue guidance of -.

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (4.90%), Price T Rowe Associates Inc. MD (2.60%), Deutsche Bank AG (2.23%), Mackenzie Financial Corp (1.96%), Dodge & Cox (1.85%) and TD Asset Management Inc. (1.51%).

How do I buy shares of Nutrien?

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $91.64.

How much money does Nutrien make?

Nutrien (NYSE:NTR) has a market capitalization of $49.70 billion and generates $27.71 billion in revenue each year. The company earns $3.15 billion in net income (profit) each year or $12.36 on an earnings per share basis.

How many employees does Nutrien have?

The company employs 23,500 workers across the globe.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The official website for the company is www.nutrien.com. The company can be reached via phone at (306) 933-8500, via email at investors@nutrien.com, or via fax at 306-933-8877.

This page (NYSE:NTR) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.